Neurostimulation Devices Market Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast by 2027

Comments · 124 Views

The increasing prevalence of chronic nervous disorders and rising demand for minimally invasive surgeries is driving the demand of the market.

The report pays special attention to the key elements of the Neurostimulation Devices market, such as drivers, restraints, opportunities, threats, risks, limitations, and other aspects. The report covers a comprehensive analysis of the competitive landscape with a detailed analysis of the company profiles, product portfolio, and business expansion strategies.

The global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the increasing prevalence of chronic nervous disorders. The rising demand for minimally invasive surgeries due to the growing preference among patients and doctors for faster recovery and shorter hospital stays is expected to drive the growth of neurostimulation devices.

The increasing prevalence of neurological disorders, such as epilepsy, Dystonia, Parkinson's diseases, is most likely to drive the demand for neurostimulation devices. Technological advancement in the healthcare infrastructure of several countries through the implementation of intelligent technologies is expected to boost the demand for the devices. Implementation of advanced technologies such as Artificial intelligence and machine learning is helping in the development of smart neuromodulation, which is most likely to benefit the patients suffering from brain damage. 

Click the link to get info@

Geographical Segmentation:

The latest research report entails an in-depth analysis of the current growth opportunities for various regions of the Neurostimulation Devices market, gauging their revenue share over the forecast timeline. Furthermore, the report analysis the year-on-year growth rate of these regions over the forecast duration. The leading market regions profiled in the report are North America, Europe, Asia Pacific, Latin America, and Middle East Africa.

Overview of the TOC of the Report:

  • Introduction, Scope, and Overview
  • Opportunities, Risks, and Drivers
  • Competition landscape analysis with sales, revenue, and price
  • Extensive Profiling of the key competitors with the sales figures, revenue, and market share
  • Regional analysis with sales, revenue, and market share for each region for the forecast period
  • Country-wise analysis of the Neurostimulation Devices market by type, application, and manufacturers
  • Neurostimulation Devices Market Segmentation based on types
  • Neurostimulation Devices Market segmentation based on applications
  • Historical and forecast estimation

Market Dynamics:

The report offers insightful information about the market dynamics of the Neurostimulation Devices market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Neurostimulation Devices market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Neurostimulation Devices market.

Key participants include BOSTON SCIENTIFIC CORPORATION, ST. JUDE MEDICAL, MEDTRONIC, NEURONETICS, INC., Codman Shurtleff, Inc., NEVRO CORPORATION, INTRAPACE, Abbott Laboratories, LivaNova PLC, and Bayer AG, among others.

Emergen Research has segmented the global Neurostimulation Devices Market on the basis of Product, Application, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Sacral Nerve stimulator
  • Spinal Cord Stimulator
  • Vagus Nerve Stimulator
  • Gastric Electric Stimulators
  • Deep Brain Stimulators

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Epilepsy
  • Depression
  • Dystonia
  • Gastroparesis
  • Pain management
  • Urinary and Fecal Incontinence
  • Essential Tremor
  • Parkinson’s Disease
  • Others

Some Key Highlights from the Report

  • In 2019, Medtronic launched the Intellis platform for the management of certain types of chronic intractable pain. The platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow. It can track patients 24/7 and help in monitoring chronic pain.
  • The spinal cord stimulator segment held the largest market share of 46.2% in 2019. The rising need for treating spinal injuries and neuropathic pain is most likely to increase the demand for the Spinal Cord Stimulators across the globe.
  • Pain management is forecasted to grow with the fastest CAGR of 14.0%. The increasing incidence of chronic and acute pain disorders among patients suffering from neurological disorders is expected to increase the usage of neurostimulation devices for pain management.

Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.

Take a Look at our Related Reports:

tea extracts market

industrial maintenance coatings market

personal care ingredients market

cast elastomers market

mice model market

business intelligence and analytics market

industrial nitrogen market

artificial intelligence systems spending market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services